STRYKER CORPORATION (NYSE:SYK) Files An 8-K Results of Operations and Financial Condition
ITEM 2.02
|
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
|
announcing its preliminary fourth quarter and full year 2016
sales. A copy of this press release is attached hereto as Exhibit
99.1.
|
ITEM 9.01
|
FINANCIAL STATEMENTS AND EXHIBITS
|
|
(d)
|
Exhibits
|
|
99.1 Press release dated January 10, 2017
|
About STRYKER CORPORATION (NYSE:SYK)
Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties. The Company’s Neurotechnology and Spine segment products consist of both neurosurgical and neurovascular devices. The Company’s products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. STRYKER CORPORATION (NYSE:SYK) Recent Trading Information
STRYKER CORPORATION (NYSE:SYK) closed its last trading session up +2.89 at 121.90 with 2,310,404 shares trading hands.
